|
Westaim Corporation (The) - Company Profile Snapshot
| Company Profile: |
Westaim Corporation (The) |
| Ticker: |
WED |
| Exchanges: |
TOR |
| 2008 Sales: |
22,397,000 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Ethical Drug Manufacturers |
| Country: |
CANADA |
| Employees: |
470 |
Business Description
Westaim Corporation (The). The Group's principal activities are to develop, manufacture and commercialize medical products that fight infection and inflammation. The Group operates through two segments: NUCRYST Pharmaceuticals and iFire Technology. NUCRYST Pharmaceuticals segment researches, develops and commercializes wound care products and pharmaceutical products based on noble metal nanocrystalline technology. iFire Technology segment develops proprietary flat-panel full color solid-state display technology. The Group operates in Canada, the United States and Europe.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
